https://ir.renovorx.com/ https://ir.renovorx.com/company-information https://ir.renovorx.com/company-information/management-team https://ir.renovorx.com/company-information/presentations https://ir.renovorx.com/company-information/contacts https://ir.renovorx.com/company-information/faq https://ir.renovorx.com/news-events/press-releases https://ir.renovorx.com/news-events/clinical-news https://ir.renovorx.com/news-events/ir-calendar-events https://ir.renovorx.com/news-events/email-alerts https://ir.renovorx.com/financial-information https://ir.renovorx.com/financial-information/financial-results https://ir.renovorx.com/financial-information/income-statement https://ir.renovorx.com/financial-information/balance-sheet https://ir.renovorx.com/financial-information/cash-flow https://ir.renovorx.com/stock-data/quote https://ir.renovorx.com/stock-data/chart https://ir.renovorx.com/stock-data/historical-data https://ir.renovorx.com/stock-data/analyst-coverage https://ir.renovorx.com/sec-filings https://ir.renovorx.com/sec-filings/all-sec-filings https://ir.renovorx.com/sec-filings/annual-reports https://ir.renovorx.com/sec-filings/quarterly-reports https://ir.renovorx.com/sec-filings/section-16-filings https://ir.renovorx.com/corporate-governance https://ir.renovorx.com/corporate-governance/board-of-directors https://ir.renovorx.com/corporate-governance/board-committees https://ir.renovorx.com/corporate-governance/governance-documents https://ir.renovorx.com/news-events/press-releases/detail/180/renovorx-reports-record-third-quarter-2026-revenue-exceeding-1-million 2026-11-05T16:05:03-05:00 https://ir.renovorx.com/news-events/press-releases/detail/179/renovorx-to-participate-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum 2026-10-28T08:30:02-04:00 https://ir.renovorx.com/news-events/press-releases/detail/178/renovorx-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-5-2026 2026-10-22T08:45:01-04:00 https://ir.renovorx.com/news-events/press-releases/detail/177/renovorx-advances-tamp-into-borderline-resectable-pancreatic-cancer-with-first-patient-enrolled-in-investigator-initiated-prism-tamp-trial 2026-10-07T08:30:04-04:00 https://ir.renovorx.com/news-events/press-releases/detail/176/renovorx-announces-peer-reviewed-publication-highlighting-the-tamp-platforms-potential-to-improve-chemotherapeutic-delivery-for-locally-advanced-pancreatic-cancer 2026-10-01T08:30:04-04:00 https://ir.renovorx.com/news-events/press-releases/detail/175/renovorx-to-present-at-h-c-wainwright-28th-annual-global-investment-conference-september-14th-16th 2026-09-02T08:30:34-04:00 https://ir.renovorx.com/news-events/press-releases/detail/174/renovorx-highlights-peer-reviewed-publication-of-pharmacokinetic-and-pharmacodynamic-pkpd-data-supporting-tamp-platforms-targeted-drug-delivery-in-locally-advanced-pancreatic-cancer 2026-08-25T08:30:02-04:00 https://ir.renovorx.com/news-events/press-releases/detail/173/renovorx-regains-compliance-with-nasdaq-minimum-bid-price-requirement 2026-08-21T08:30:01-04:00 https://ir.renovorx.com/news-events/press-releases/detail/172/renovorx-receives-notice-of-allowance-for-new-u-s-patent-covering-renovocath-an-advanced-dual-occlusion-catheter-for-targeted-therapeutic-drug-delivery-for-cancer-treatment 2026-08-20T08:30:10-04:00 https://ir.renovorx.com/news-events/press-releases/detail/171/renovorx-reports-record-second-quarter-2026-results-driven-by-accelerating-commercial-adoption-and-61-sequential-quarterly-revenue-growth 2026-08-12T16:06:12-04:00 https://ir.renovorx.com/news-events/press-releases/detail/170/renovorx-achieves-major-milestone-with-full-enrollment-in-phase-iii-tiger-pac-trial-for-locally-advanced-pancreatic-cancer 2026-08-11T08:30:01-04:00 https://ir.renovorx.com/news-events/press-releases/detail/169/renovorx-announces-first-commercial-clinical-use-of-renovocath-in-sarcoma-patient-treatment-marking-expansion-of-targeted-drug-delivery-device-to-other-solid-tumors 2026-08-06T08:30:50-04:00 https://ir.renovorx.com/news-events/press-releases/detail/168/renovorx-to-highlight-tamp-platform-at-jonestrading-virtual-key-opinion-leader-webinar-on-the-evolving-pancreatic-cancer-landscape-august-13th 2026-08-04T08:30:10-04:00 https://ir.renovorx.com/news-events/press-releases/detail/167/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-conference-call-on-august-12th-at-4-30-p-m-et 2026-07-29T08:30:07-04:00 https://ir.renovorx.com/news-events/press-releases/detail/166/renovorx-highlights-peer-reviewed-publication-supporting-intra-arterial-gemcitabine-delivery-via-tamp-in-locally-advanced-pancreatic-cancer 2026-06-11T08:30:03-04:00 https://ir.renovorx.com/news-events/press-releases/detail/165/renovorx-ceo-shaun-bagai-to-present-at-the-iaccess-alpha-virtual-best-ideas-summer-investment-conference-2026-on-june-23rd 2026-06-04T08:30:04-04:00 https://ir.renovorx.com/news-events/press-releases/detail/164/renovorx-announces-fda-orphan-drug-designation-granted-oxaliplatin-for-the-treatment-of-pancreatic-cancer 2026-05-28T08:30:03-04:00 https://ir.renovorx.com/news-events/press-releases/detail/163/renovorx-announces-promising-pharmacokinetic-data-using-the-tamp-platform-presented-at-the-2026-asco-annual-meeting 2026-05-26T08:30:02-04:00 https://ir.renovorx.com/news-events/press-releases/detail/162/renovorx-to-present-at-the-alliance-global-partners-virtual-annual-healthcare-company-showcase-on-may-20th 2026-05-19T08:30:06-04:00 https://ir.renovorx.com/news-events/press-releases/detail/161/renovorx-reports-record-first-quarter-2026-increasing-revenue-by-136-quarter-over-quarter 2026-05-14T16:05:21-04:00 https://ir.renovorx.com/news-events/press-releases/detail/160/renovorx-to-host-first-quarter-2026-financial-results-and-business-highlights-conference-call-on-may-14th-at-4-30-pm-et 2026-04-29T08:30:03-04:00 https://ir.renovorx.com/news-events/press-releases/detail/159/renovorx-announces-pharmacokinetic-and-pharmacodynamic-data-abstract-supporting-the-tamp-therapy-platform-accepted-for-presentation-at-the-2026-asco-annual-meeting 2026-04-23T08:30:05-04:00 https://ir.renovorx.com/news-events/press-releases/detail/158/clinical-data-supporting-targeted-chemotherapeutic-delivery-via-renovorxs-tamp-therapy-platform-presented-at-2026-sir-annual-scientific-meeting 2026-04-14T08:30:06-04:00 https://ir.renovorx.com/news-events/press-releases/detail/157/renovorx-secures-first-notice-of-allowance-for-japanese-patent-covering-its-renovocath-device-for-targeted-local-drug-delivery-via-the-vasa-vasorum 2026-04-08T08:30:04-04:00 https://ir.renovorx.com/news-events/press-releases/detail/156/renovorx-named-to-fast-companys-annual-list-of-the-worlds-most-innovative-companies-of-2026 2026-04-01T14:20:17-04:00 https://ir.renovorx.com/news-events/press-releases/detail/155/renovorx-reports-full-year-2025-financial-results-and-provides-business-update 2026-03-30T16:05:03-04:00 https://ir.renovorx.com/news-events/press-releases/detail/154/renovorx-announces-key-phase-iii-milestone-tiger-pac-trial-surpasses-100-randomized-patients-as-study-nears-completion-of-enrollment 2026-03-26T08:30:07-04:00 https://ir.renovorx.com/news-events/press-releases/detail/153/renovorx-announces-closing-of-oversubscribed-10-million-at-market-private-placement 2026-03-24T09:48:45-04:00 https://ir.renovorx.com/news-events/press-releases/detail/152/renovorx-to-host-fourth-quarter-and-full-year-2025-financial-results-and-business-highlights-conference-call-on-march-30th-at-4-30-p-m-et 2026-03-20T08:30:02-04:00 https://ir.renovorx.com/news-events/press-releases/detail/151/renovorx-announces-10-million-at-market-private-placement 2026-03-18T08:35:19-04:00 https://ir.renovorx.com/news-events/press-releases/detail/150/renovorx-advancing-renovocath-adoption-at-u-s-cancer-centers-strengthening-clinical-and-commercial-momentum 2026-02-27T08:30:02-05:00 https://ir.renovorx.com/news-events/press-releases/detail/149/renovorx-announces-acceptance-of-clinical-data-abstract-at-2026-society-of-interventional-radiology-annual-scientific-meeting 2026-02-26T08:30:08-05:00 https://ir.renovorx.com/news-events/press-releases/detail/148/renovorx-establishes-renovocath-medical-advisory-board 2026-02-10T08:30:06-05:00 https://ir.renovorx.com/news-events/press-releases/detail/147/renovorx-appoints-experienced-public-company-executive-mark-voll-as-chief-financial-officer 2026-02-05T08:30:05-05:00 https://ir.renovorx.com/news-events/press-releases/detail/146/renovorx-announces-clinical-data-supporting-the-tamp-therapy-platform-will-be-presented-at-the-sio-2026-annual-scientific-meeting 2026-02-04T08:30:07-05:00 https://ir.renovorx.com/news-events/press-releases/detail/145/renovorx-announces-acceptance-of-clinical-data-abstract-at-2026-society-of-interventional-oncology-annual-scientific-meeting 2026-01-28T08:30:03-05:00 https://ir.renovorx.com/news-events/press-releases/detail/144/renovorx-expands-renovocath-commercial-adoption-to-nine-active-cancer-centers-including-city-of-hope-cancer-center-and-moffitt-cancer-center 2026-01-20T08:30:05-05:00 https://ir.renovorx.com/news-events/press-releases/detail/143/renovorx-to-participate-in-alphanorth-capital-event-january-16-18-2026 2026-01-14T08:30:05-05:00 https://ir.renovorx.com/news-events/press-releases/detail/142/renovorx-to-announce-promising-new-clinical-data-using-its-tamp-therapy-platform-in-an-abstract-to-be-presented-at-asco-gi-2026 2026-01-08T08:30:05-05:00 https://ir.renovorx.com/news-events/press-releases/detail/141/renovorx-announces-acceptance-of-clinical-data-abstract-at-the-asco-gastrointestinal-cancers-symposium-2026 2025-12-11T08:30:02-05:00 https://ir.renovorx.com/news-events/press-releases/detail/140/renovorx-ceo-shaun-bagai-to-present-at-iaccess-alpha-virtual-best-ideas-winter-investment-conference-2025-on-december-9th 2025-12-01T08:30:04-05:00 https://ir.renovorx.com/news-events/press-releases/detail/139/renovorx-ceo-shaun-bagai-to-present-at-the-alliance-global-partners-emerging-agbiotechbio-solutions-virtual-showcase-on-november-20th 2025-11-19T08:30:04-05:00 https://ir.renovorx.com/news-events/press-releases/detail/138/renovorx-reports-third-quarter-2025-financial-results-including-approximately-900000-in-year-to-date-revenue-and-provides-business-update 2025-11-13T16:05:06-05:00 https://ir.renovorx.com/news-events/press-releases/detail/137/renovorx-strengthens-scientific-advisory-board-sab-with-pancreatic-cancer-expert-timothy-donahue-md 2025-11-06T08:30:04-05:00 https://ir.renovorx.com/news-events/press-releases/detail/136/renovorx-ceo-shaun-bagai-to-participate-at-the-canaccord-genuity-medtech-diagnostics-digital-health-services-forum-on-november-20th 2025-11-04T08:30:29-05:00 https://ir.renovorx.com/news-events/press-releases/detail/135/renovorx-to-host-third-quarter-2025-financial-results-and-business-highlights-conference-call-on-november-13th-at-4-30-p-m-et 2025-10-27T08:30:14-04:00 https://ir.renovorx.com/news-events/press-releases/detail/134/renovorx-expands-scientific-advisory-board-with-internationally-renowned-interventional-oncologist-thierry-de-bare-md-phd 2025-10-09T08:30:12-04:00 https://ir.renovorx.com/news-events/press-releases/detail/133/renovorxs-panther-post-marketing-registry-study-progresses-with-first-clinical-procedure-and-addition-of-two-participating-clinical-sites 2025-09-25T08:30:08-04:00 https://ir.renovorx.com/news-events/press-releases/detail/132/renovorx-ceo-shaun-bagai-to-present-at-iaccess-alpha-virtual-best-ideas-fall-investment-conference-2025-on-september-16th 2025-09-11T08:30:09-04:00 https://ir.renovorx.com/news-events/press-releases/detail/131/renovorx-ceo-shaun-bagai-to-present-at-h-c-wainwrights-27th-annual-global-investment-conference-in-new-york-city-september-8-10-2025 2025-08-20T08:30:02-04:00 https://ir.renovorx.com/news-events/press-releases/detail/130/renovorx-reports-commercial-revenue-growth-in-the-second-quarter-2025-and-announces-positive-independent-data-monitoring-committee-recommendation-to-continue-pivotal-phase-iii-tiger-pac-trial-based-on-interim-data-review 2025-08-14T16:06:48-04:00 https://ir.renovorx.com/news-events/press-releases/detail/129/renovorx-expands-u-s-commercialization-efforts-for-the-renovocath-device-with-growing-customer-demand-and-key-leadership-hire 2025-08-06T08:30:12-04:00 https://ir.renovorx.com/news-events/press-releases/detail/128/renovorx-launches-multi-center-post-marketing-registry-study-to-evaluate-cancer-treatment-delivered-by-renovocath-device-to-solid-tumors 2025-07-28T08:30:03-04:00 https://ir.renovorx.com/news-events/press-releases/detail/127/renovorx-to-host-second-quarter-2025-financial-results-and-business-highlights-conference-call-on-august-14th-at-4-30-p-m-et 2025-07-14T08:30:03-04:00 https://ir.renovorx.com/news-events/press-releases/detail/126/renovorx-reports-first-quarter-2025-financial-results-and-business-highlights 2025-05-15T16:05:07-04:00 https://ir.renovorx.com/news-events/press-releases/detail/125/renovorx-to-participate-in-fireside-chat-at-a-g-p-virtual-healthcare-company-showcase-on-may-21st 2025-05-14T08:30:02-04:00 https://ir.renovorx.com/news-events/press-releases/detail/124/u-s-patent-office-issues-new-patent-to-renovorx-for-novel-trans-arterial-micro-profusion-tamp-therapy-platform 2025-05-06T08:30:04-04:00 https://ir.renovorx.com/news-events/press-releases/detail/123/renovorx-to-host-first-quarter-2025-financial-results-conference-call-on-may-15th-at-4-30-p-m-et 2025-05-01T08:30:02-04:00 https://ir.renovorx.com/news-events/press-releases/detail/122/johns-hopkins-medicine-initiates-patient-enrollment-for-renovorxs-ongoing-phase-iii-tiger-pac-clinical-trial 2025-04-29T08:30:06-04:00 https://ir.renovorx.com/news-events/press-releases/detail/121/renovorx-increases-u-s-production-of-renovocath-devices-to-meet-growing-demand-from-oncology-community 2025-04-16T08:30:03-04:00 https://ir.renovorx.com/news-events/press-releases/detail/120/renovorx-to-present-at-ld-micro-invitational-xv-conference-in-new-york-on-april-10th 2025-04-04T08:30:01-04:00 https://ir.renovorx.com/news-events/press-releases/detail/119/renovorx-reports-initial-revenues-from-renovocath-commercialization-and-provides-update-on-ongoing-pivotal-phase-iii-tiger-pac-clinical-trial 2025-04-01T08:30:09-04:00 https://ir.renovorx.com/news-events/press-releases/detail/118/renovorx-highlights-new-human-pharmacokinetic-data-abstract-at-sso-2025-annual-meeting 2025-03-28T08:00:02-04:00 https://ir.renovorx.com/news-events/press-releases/detail/117/renovorx-pre-clinical-results-supporting-tamp-as-a-targeted-locoregional-drug-delivery-platform-to-receive-award-at-sir-2025-annual-scientific-meeting 2025-03-26T08:00:03-04:00 https://ir.renovorx.com/news-events/press-releases/detail/116/renovorx-ceo-to-provide-strategic-update-during-fireside-chat-on-thursday-april-3rd-at-12-00-p-m-et 2025-03-20T08:00:09-04:00 https://ir.renovorx.com/news-events/press-releases/detail/115/renovorx-announces-abstract-presentation-at-the-society-of-surgical-oncology-sso-2025 2025-03-19T08:00:10-04:00 https://ir.renovorx.com/news-events/press-releases/detail/114/renovorx-advances-commercialization-of-renovocath-with-several-new-purchase-orders-including-customer-reorders 2025-02-26T08:00:12-05:00 https://ir.renovorx.com/news-events/press-releases/detail/113/renovorx-highlights-promising-pre-clinical-data-abstract-tamp-therapy-platform-offers-potential-to-improve-localized-and-targeted-drug-delivery 2025-02-13T08:00:12-05:00 https://ir.renovorx.com/news-events/press-releases/detail/112/renovorx-announces-closing-of-12-1-million-underwritten-public-offering-of-common-stock 2025-02-11T07:00:09-05:00 https://ir.renovorx.com/news-events/press-releases/detail/111/renovorx-announces-pricing-of-12-1-million-underwritten-public-offering-of-common-stock 2025-02-06T20:49:01-05:00 https://ir.renovorx.com/news-events/press-releases/detail/110/renovorx-announces-proposed-public-offering 2025-02-06T16:05:02-05:00 https://ir.renovorx.com/news-events/press-releases/detail/109/renovorx-highlights-promising-pharmacokinetic-data-abstract-presented-at-asco-gi-2025 2025-01-27T08:00:09-05:00 https://ir.renovorx.com/news-events/press-releases/detail/108/renovorx-announces-acceptance-of-abstract-for-presentation-at-asco-gastrointestinal-cancers-symposium-2025 2025-01-08T08:00:19-05:00 https://ir.renovorx.com/news-events/press-releases/detail/107/renovorx-continues-to-grow-intellectual-property-portfolio-for-its-novel-drug-delivery-therapy-platform 2024-12-30T08:00:02-05:00 https://ir.renovorx.com/news-events/press-releases/detail/106/renovorx-initiates-patient-enrollment-at-scri-oncology-partners-for-ongoing-pivotal-phase-iii-tiger-pac-clinical-trial-in-locally-advanced-pancreatic-cancer 2024-12-11T08:00:09-05:00 https://ir.renovorx.com/news-events/press-releases/detail/105/renovorx-ceo-to-host-investor-fireside-chat-on-tuesday-december-17th-at-4-30-p-m-et 2024-12-10T08:00:25-05:00 https://ir.renovorx.com/news-events/press-releases/detail/104/renovorx-receives-first-purchase-orders-for-its-fda-cleared-renovocath-delivery-system 2024-12-05T08:00:16-05:00 https://ir.renovorx.com/news-events/press-releases/detail/103/northwell-health-cancer-institute-launches-patient-enrollment-in-renovorxs-ongoing-pivotal-phase-iii-tiger-pac-clinical-trial 2024-11-20T08:45:01-05:00 https://ir.renovorx.com/news-events/press-releases/detail/102/renovorx-reports-third-quarter-2024-financial-results-and-operational-highlights 2024-11-14T08:00:28-05:00 https://ir.renovorx.com/news-events/press-releases/detail/101/renovorx-increases-production-of-fda-cleared-renovocath-delivery-system-in-response-to-strong-demand-from-oncology-and-interventional-radiology-physicians 2024-09-25T08:30:06-04:00 https://ir.renovorx.com/news-events/press-releases/detail/100/renovorx-announces-presentation-at-symposium-on-clinical-interventional-oncology-highlighting-tamp-for-targeted-treatment-of-locally-advanced-pancreatic-cancer 2024-09-19T08:30:04-04:00 https://ir.renovorx.com/news-events/press-releases/detail/99/renovorx-ceo-shaun-bagai-to-present-at-h-c-wainwrights-26th-annual-global-investment-conference-on-september-9-2024-in-new-york 2024-08-27T08:30:02-04:00 https://ir.renovorx.com/news-events/press-releases/detail/98/renovorx-announces-first-patient-enrolled-at-university-of-nebraska-medical-center-for-the-ongoing-pivotal-phase-iii-tiger-pac-clinical-trial 2024-08-14T08:30:05-04:00 https://ir.renovorx.com/news-events/press-releases/detail/97/renovorx-announces-publication-of-positive-early-stage-clinical-data-in-international-peer-reviewed-journal-the-oncologist 2024-07-31T08:30:03-04:00 https://ir.renovorx.com/news-events/press-releases/detail/96/renovorx-announces-acceptance-for-publication-in-the-international-peer-reviewed-journal-the-oncologist 2024-07-08T08:30:01-04:00 https://ir.renovorx.com/news-events/press-releases/detail/95/university-of-nebraska-medical-center-launches-patient-enrollment-for-renovorxs-pivotal-phase-iii-tiger-pac-clinical-trial 2024-06-26T08:30:05-04:00 https://ir.renovorx.com/news-events/press-releases/detail/94/renovorx-appoints-ryan-witt-as-senior-vice-president-head-of-corporate-strategy-and-partnerships 2024-06-10T09:08:38-04:00 https://ir.renovorx.com/news-events/press-releases/detail/93/renovorx-ceo-issues-update-letter-to-shareholders 2024-05-30T08:30:03-04:00 https://ir.renovorx.com/news-events/press-releases/detail/92/publication-of-results-of-pre-clinical-studies-support-efficacy-and-drug-delivery-mechanism-potential-of-renovorxs-tamp-therapy-platform-to-improve-targeted-cancer-drug-treatment-delivery 2024-05-21T09:00:03-04:00 https://ir.renovorx.com/news-events/press-releases/detail/91/renovorx-to-participate-in-fireside-chat-at-the-a-g-p-virtual-healthcare-company-showcase-on-may-21-2024 2024-05-14T09:00:01-04:00 https://ir.renovorx.com/news-events/press-releases/detail/90/renovorx-ceo-shaun-r-bagai-to-present-at-the-aegis-capital-virtual-conference-on-may-9-2024 2024-05-02T09:00:06-04:00 https://ir.renovorx.com/news-events/press-releases/detail/89/renovorx-regains-compliance-with-nasdaq-stockholders-equity-requirement 2024-04-18T08:30:02-04:00 https://ir.renovorx.com/news-events/press-releases/detail/88/renovorx-highlights-recent-presentation-of-clinical-data-abstract-at-the-2024-society-of-interventional-radiology-annual-scientific-meeting 2024-04-16T08:30:04-04:00 https://ir.renovorx.com/news-events/press-releases/detail/87/renovorx-closes-11-1-million-private-placement-providing-cash-runway-into-2026 2024-04-15T08:00:01-04:00 https://ir.renovorx.com/news-events/press-releases/detail/86/renovorx-announces-11-1-million-at-market-private-placement 2024-04-08T08:30:02-04:00 https://ir.renovorx.com/news-events/press-releases/detail/85/renovorx-to-present-at-the-canaccord-genuity-horizons-in-oncology-virtual-conference-on-april-15-2024 2024-04-05T08:30:01-04:00 https://ir.renovorx.com/news-events/press-releases/detail/84/renovorx-to-present-at-the-36th-annual-roth-conference-on-march-19-2024 2024-03-12T09:00:05-04:00 https://ir.renovorx.com/news-events/press-releases/detail/83/renovorx-highlights-key-leadership-promotions 2024-03-08T16:05:02-05:00 https://ir.renovorx.com/news-events/press-releases/detail/82/renovorx-ceo-issues-letter-to-shareholders 2024-02-06T08:30:03-05:00 https://ir.renovorx.com/news-events/press-releases/detail/81/renovorx-closes-6-1-million-private-placement 2024-01-29T08:30:02-05:00 https://ir.renovorx.com/news-events/press-releases/detail/80/renovorx-engages-oklahoma-university-ou-health-as-first-clinical-site-in-preparation-for-the-pivotal-phase-iii-cougar-clinical-trial-in-bile-duct-cancer 2023-12-21T08:30:02-05:00 https://ir.renovorx.com/news-events/press-releases/detail/79/renovorx-announces-clinical-data-abstract-at-the-2024-society-of-interventional-radiology-annual-scientific-meeting 2023-12-19T08:30:02-05:00 https://ir.renovorx.com/news-events/press-releases/detail/78/renovorx-files-new-international-patent-for-novel-targeted-combination-drug-delivery-oncology-therapy-platform 2023-12-13T08:31:01-05:00 https://ir.renovorx.com/news-events/press-releases/detail/77/renovorx-expands-scientific-advisory-board-with-appointment-of-michel-ducreux-m-d-ph-d 2023-11-16T08:35:01-05:00 https://ir.renovorx.com/news-events/press-releases/detail/76/renovorx-reports-third-quarter-2023-financial-results-and-operational-highlights 2023-11-14T08:30:04-05:00 https://ir.renovorx.com/news-events/press-releases/detail/75/renovorx-to-present-at-the-roth-mkm-healthcare-opportunities-conference-on-october-12-2023 2023-10-02T08:30:03-04:00 https://ir.renovorx.com/news-events/press-releases/detail/74/renovorx-reports-second-quarter-2023-financial-results-and-operational-highlights 2023-08-17T08:30:01-04:00 https://ir.renovorx.com/news-events/press-releases/detail/73/renovorx-to-present-at-the-43rd-annual-canaccord-genuity-growth-conference 2023-07-31T08:30:01-04:00 https://ir.renovorx.com/news-events/press-releases/detail/72/renovorx-and-imugene-announce-collaboration-to-deliver-oncolytic-virus-therapy-using-proprietary-trans-arterial-micro-perfusion-tamp-platform 2023-07-20T08:00:03-04:00 https://ir.renovorx.com/news-events/press-releases/detail/71/renovorx-announces-new-positive-interim-phase-iii-data-demonstrating-renovogem-delays-cancer-progression-by-eight-months-in-locally-advanced-pancreatic-cancer 2023-06-29T08:00:05-04:00 https://ir.renovorx.com/news-events/press-releases/detail/70/renovorx-appoints-margaret-a-tempero-m-d-to-scientific-advisory-board 2023-06-20T08:30:01-04:00 https://ir.renovorx.com/news-events/press-releases/detail/69/renovorx-announces-roth-capital-key-opinion-leader-kol-webcast-on-june-15 2023-06-12T08:30:02-04:00 https://ir.renovorx.com/news-events/press-releases/detail/68/renovorx-initiates-patient-enrollment-at-university-of-texas-southwestern-medical-center-for-pivotal-phase-iii-tiger-pac-clinical-trial 2023-06-01T08:30:02-04:00 https://ir.renovorx.com/news-events/press-releases/detail/67/renovorx-announces-late-breaking-oral-presentation-at-2023-esmo-world-congress-on-gastrointestinal-cancer 2023-05-25T08:30:04-04:00 https://ir.renovorx.com/news-events/press-releases/detail/66/renovorx-to-present-at-the-ld-micro-invitational-xiii-conference 2023-05-24T08:30:01-04:00 https://ir.renovorx.com/news-events/press-releases/detail/65/renovorx-reports-first-quarter-2023-financial-results-and-operational-highlights 2023-05-15T08:30:04-04:00 https://ir.renovorx.com/news-events/press-releases/detail/64/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event 2023-05-01T08:30:04-04:00 https://ir.renovorx.com/news-events/press-releases/detail/63/renovorx-to-participate-in-the-aegis-capital-virtual-conference-on-may-3-2023 2023-04-28T08:30:04-04:00 https://ir.renovorx.com/news-events/press-releases/detail/62/renovorx-appoints-former-chief-medical-officer-of-schering-plough-robert-j-spiegel-md-facp-to-board-of-directors 2023-04-27T08:30:03-04:00 https://ir.renovorx.com/news-events/press-releases/detail/61/renovorx-presenting-phase-iii-clinical-trial-interim-analysis-data-of-the-tiger-pac-study-at-american-association-for-cancer-research-annual-meeting-underway-in-orlando-florida 2023-04-14T08:30:02-04:00 https://ir.renovorx.com/news-events/press-releases/detail/60/renovorx-appoints-leesa-gentry-as-senior-vice-president-of-clinical-operations 2023-04-11T08:30:05-04:00 https://ir.renovorx.com/news-events/press-releases/detail/59/renovorx-inc-announces-5-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules 2023-03-30T12:20:01-04:00 https://ir.renovorx.com/news-events/press-releases/detail/58/renovorx-announces-positive-new-data-from-phase-iii-clinical-trial-interim-analysis-60-survival-benefit-and-fewer-side-effects-than-systemic-chemotherapy 2023-03-30T08:30:03-04:00 https://ir.renovorx.com/news-events/press-releases/detail/57/renovorx-phase-iii-open-label-tiger-pac-interim-analysis-shows-promising-data-that-support-continued-clinical-investigation-of-renovogem-as-a-treatment-option-for-locally-advanced-pancreatic-cancer 2023-03-08T10:09:27-05:00 https://ir.renovorx.com/news-events/press-releases/detail/56/renovorx-reports-full-year-2022-financial-results-and-achievement-of-important-phase-iii-clinical-study-milestone 2023-03-02T08:30:05-05:00 https://ir.renovorx.com/news-events/press-releases/detail/55/renovorx-to-present-at-the-35th-annual-roth-conference-on-march-13-2023 2023-03-13T14:23:28-04:00 https://ir.renovorx.com/news-events/press-releases/detail/54/renovorx-to-present-at-the-sequire-biotechnology-virtual-conference-on-february-2-2023 2023-01-25T08:30:05-05:00 https://ir.renovorx.com/news-events/press-releases/detail/53/renovorx-announces-initial-results-in-pharmacokinetic-pk-substudy-data-on-renovogem-supports-potential-for-renovotamp-therapy-platform-to-increase-local-gemcitabine-chemotherapy-delivery-and-decrease-side-effects-of-pancreatic-cancer-treatment 2023-01-18T08:30:01-05:00 https://ir.renovorx.com/news-events/press-releases/detail/52/renovorx-strengthens-intellectual-property-ip-portfolio-with-eighth-us-patent 2023-01-05T08:30:06-05:00 https://ir.renovorx.com/news-events/press-releases/detail/51/renovorx-announces-acceptance-of-four-clinical-data-abstracts-at-the-2023-asco-gastrointestinal-cancers-asco-gi-symposium 2022-12-15T08:30:05-05:00 https://ir.renovorx.com/news-events/press-releases/detail/50/renovorx-announces-presentations-at-the-advanced-interventional-management-symposium-aimsymposium-highlighting-its-innovative-renovotamp-therapy-platform-for-targeted-treatment-of-cancers 2022-11-17T08:30:02-05:00 https://ir.renovorx.com/news-events/press-releases/detail/49/renovorx-reports-third-quarter-2022-financial-results 2022-11-14T08:30:03-05:00 https://ir.renovorx.com/news-events/press-releases/detail/48/renovorx-to-participate-in-roth-capital-deep-dive-webinar-on-october-27-2022-at-1-00-p-m-et 2022-10-21T08:30:03-04:00 https://ir.renovorx.com/news-events/press-releases/detail/47/renovorx-to-participate-in-upcoming-october-2022-investor-conferences 2022-10-04T08:00:14-04:00 https://ir.renovorx.com/news-events/press-releases/detail/46/renovorx-announces-presentation-at-symposium-on-clinical-interventional-oncology-cio-highlighting-its-innovative-therapy-platform-for-targeted-treatment-of-pancreatic-cancer 2022-09-28T08:30:02-04:00 https://ir.renovorx.com/news-events/press-releases/detail/45/renovorx-appoints-angela-gill-nelms-as-chief-operating-officer 2022-09-19T08:30:03-04:00 https://ir.renovorx.com/news-events/press-releases/detail/44/renovorx-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022 2022-09-07T08:00:44-04:00 https://ir.renovorx.com/news-events/press-releases/detail/43/renovorx-reports-second-quarter-2022-financial-results 2022-08-15T08:00:05-04:00 https://ir.renovorx.com/news-events/press-releases/detail/42/renovorx-appoints-james-ahlers-as-chief-financial-officer 2022-07-19T08:34:42-04:00 https://ir.renovorx.com/news-events/press-releases/detail/41/renovorx-launches-the-renovorx-story-video-series 2022-07-13T08:00:01-04:00 https://ir.renovorx.com/news-events/press-releases/detail/40/renovorx-and-tiger-pac-leadership-to-host-renovotamp-webinar-on-june-21-2022 2022-06-09T08:30:03-04:00 https://ir.renovorx.com/news-events/press-releases/detail/39/renovorx-to-participate-in-the-university-of-cambridges-academy-of-therapeutic-sciences-gateway-to-translation-seminar-series-on-june-8-2022 2022-06-02T08:30:02-04:00 https://ir.renovorx.com/news-events/press-releases/detail/38/renovorx-to-present-preclinical-research-data-demonstrating-its-innovative-therapy-platforms-potential-utility-for-the-treatment-of-bile-duct-cancer 2022-05-19T08:30:03-04:00 https://ir.renovorx.com/news-events/press-releases/detail/37/renovorx-to-participate-in-upcoming-h-c-wainwright-global-investment-conference-in-may-2022 2022-05-18T08:00:00-04:00 https://ir.renovorx.com/news-events/press-releases/detail/36/renovorx-reports-first-quarter-2022-financial-results 2022-05-16T07:30:03-04:00 https://ir.renovorx.com/news-events/press-releases/detail/5/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event-to-end-pancreatic-cancer 2022-04-20T11:55:55-04:00 https://ir.renovorx.com/news-events/press-releases/detail/6/renovorx-reports-full-year-2021-financial-results 2022-04-20T11:55:55-04:00 https://ir.renovorx.com/news-events/press-releases/detail/7/renovorx-to-participate-in-march-2022-investor-conferences 2022-04-20T11:55:55-04:00 https://ir.renovorx.com/news-events/press-releases/detail/8/renovorx-enrolls-first-pancreatic-cancer-patient-at-columbia-universitys-new-york-presbyterian-hospital-irving-medical-center-in-ongoing-tiger-pac-phase-3-clinical-trial 2022-04-20T11:55:56-04:00 https://ir.renovorx.com/news-events/press-releases/detail/9/renovorx-to-host-delivering-therapy-where-it-matters-fireside-chat-with-ceo-shaun-bagai-on-february-23rd-at-12-p-m-et 2022-04-20T11:55:56-04:00 https://ir.renovorx.com/news-events/press-releases/detail/10/renovorx-announces-presentation-at-the-2022-spectrum-conference-highlighting-its-innovative-renovotamp-therapy-for-targeted-treatment-of-cancer 2022-04-20T11:55:56-04:00 https://ir.renovorx.com/news-events/press-releases/detail/11/renovorx-to-present-at-the-h-c-wainwright-bioconnect-virtual-conference 2022-04-20T11:55:56-04:00 https://ir.renovorx.com/news-events/press-releases/detail/12/renovorx-announces-third-quarter-2021-financial-results 2022-04-20T11:55:56-04:00 https://ir.renovorx.com/news-events/press-releases/detail/13/renovorx-announces-presentation-of-final-data-from-rr2-observational-registry-study-at-2021-pancreas-club-annual-meeting 2022-04-20T11:55:56-04:00 https://ir.renovorx.com/news-events/press-releases/detail/14/presentation-during-new-advances-in-the-management-of-pancreatic-cancer-course-highlights-intra-arterial-chemotherapy-as-a-potential-innovative-treatment-for-pancreatic-cancer 2022-04-20T11:55:56-04:00 https://ir.renovorx.com/news-events/press-releases/detail/15/renovorx-receives-new-510k-clearance-for-its-renovocath-delivery-system-designed-for-targeted-treatment-of-solid-tumors 2022-04-20T11:55:56-04:00 https://ir.renovorx.com/news-events/press-releases/detail/16/renovorx-announces-pricing-of-initial-public-offering 2022-04-20T11:56:35-04:00 https://ir.renovorx.com/news-events/press-releases/detail/17/renovorx-announces-issuance-of-seventh-u-s-patent 2022-04-20T11:56:36-04:00 https://ir.renovorx.com/news-events/press-releases/detail/18/renovorx-continues-with-strong-momentum-and-reaches-milestone-of-100th-patient-enrolled-in-its-phase-iii-tiger-pac-clinical-trial 2022-04-20T11:56:36-04:00 https://ir.renovorx.com/news-events/press-releases/detail/19/renovorx-named-2020-drug-delivery-technology-winner-in-the-fierce-innovation-awards-for-life-sciences 2022-04-20T11:56:36-04:00 https://ir.renovorx.com/news-events/press-releases/detail/20/renovorx-announces-issuance-of-sixth-u-s-patent 2022-04-20T11:56:36-04:00 https://ir.renovorx.com/news-events/press-releases/detail/21/renovorx-announces-orphan-drug-designation-granted-for-treating-bile-duct-cancer 2022-04-20T11:56:36-04:00 https://ir.renovorx.com/news-events/press-releases/detail/22/renovorx-announces-issuance-of-fifth-u-s-patent 2022-04-20T11:56:36-04:00 https://ir.renovorx.com/news-events/press-releases/detail/23/renovorx-announces-10-million-financing-for-innovative-treatment-for-advanced-pancreatic-cancer 2022-04-20T11:56:36-04:00 https://ir.renovorx.com/news-events/press-releases/detail/24/researchers-report-survival-benefits-with-use-of-renovocath-in-patients-with-locally-advanced-pancreatic-tumors 2022-04-20T11:56:37-04:00 https://ir.renovorx.com/news-events/press-releases/detail/25/renovorx-announces-fda-clearance-for-expanded-labeling 2022-04-20T11:56:37-04:00 https://ir.renovorx.com/news-events/press-releases/detail/26/renovorx-announces-the-u-s-patent-and-trademark-office-issuance-of-two-patents 2022-04-20T11:56:37-04:00 https://ir.renovorx.com/news-events/press-releases/detail/27/renovorx-joins-stanford-backed-startx-med-program 2022-04-20T11:56:37-04:00 https://ir.renovorx.com/news-events/press-releases/detail/28/renovorx-receives-ce-mark-for-renovocath 2022-04-20T11:56:37-04:00 https://ir.renovorx.com/news-events/press-releases/detail/29/first-patient-enrolled-in-study-using-the-renovocath 2022-04-20T11:56:37-04:00 https://ir.renovorx.com/news-events/press-releases/detail/30/el-camino-hospital-performs-first-in-human-use-of-renovocath-catheter 2022-04-20T11:56:37-04:00 https://ir.renovorx.com/news-events/press-releases/detail/31/renovocath-rc120-catheter-receives-fda-clearance 2022-04-20T11:56:37-04:00 https://ir.renovorx.com/news-events/press-releases/detail/32/renovorx-announces-the-u-s-patent-and-trademark-office-issuance-of-patent 2022-04-20T11:56:37-04:00 https://ir.renovorx.com/news-events/press-releases/detail/33/renovorx-board-names-shaun-r-bagai-as-ceo 2022-04-20T11:56:38-04:00 https://ir.renovorx.com/news-events/press-releases/detail/34/renovorx-announces-closing-of-a-1-15-million-series-b-financing 2022-04-20T11:56:38-04:00 https://ir.renovorx.com/news-events/press-releases/detail/35/renovorx-named-winner-of-2013-tie50-top-startup 2022-04-20T11:56:38-04:00 https://ir.renovorx.com/news-events/ir-calendar-events/detail/20261105-third-quarter-2026-financial-results-conference-call 2026-10-22T08:53:39-04:00 https://ir.renovorx.com/news-events/ir-calendar-events/detail/20260914-h-c-wainwright-28th-annual-global-investment-conference 2026-09-28T17:01:38-04:00 https://ir.renovorx.com/news-events/ir-calendar-events/detail/20260813-jones-hosts-the-evolving-pancreatic-cancer-landscape-the-role-of-renovorxs-tamp-platform-and-emerging-clinical-advances 2026-09-28T17:01:38-04:00 https://ir.renovorx.com/news-events/ir-calendar-events/detail/20260812-second-quarter-2026-financial-results-conference-call 2026-09-28T17:01:38-04:00 https://ir.renovorx.com/news-events/ir-calendar-events/detail/20260623-iaccess-alpha-virtual-best-ideas-summer-investement-conference-2026 2026-09-28T17:01:38-04:00 https://ir.renovorx.com/news-events/ir-calendar-events/detail/20260520-agp-virtual-annual-healthcare-company-showcase-details 2026-09-28T17:01:37-04:00 https://ir.renovorx.com/news-events/ir-calendar-events/detail/20260514-first-quarter-2026-financial-results-conference-call 2026-09-28T17:01:37-04:00 https://ir.renovorx.com/sec-filings/all-sec-filings/content/0001104659-26-123910/primary_doc.html 2026-11-06T16:32:43-05:00 https://ir.renovorx.com/sec-filings/all-sec-filings/content/0001193125-26-449910/rnxt-20260930.htm 2026-11-05T16:40:58-05:00 https://ir.renovorx.com/sec-filings/all-sec-filings/content/0001193125-26-449890/rnxt-20261105.htm 2026-11-05T16:36:34-05:00 https://ir.renovorx.com/sec-filings/all-sec-filings/content/0001493152-26-047333/formrw.htm 2026-10-16T07:00:48-04:00 https://ir.renovorx.com/sec-filings/all-sec-filings/content/0001493152-26-045582/ownership.html 2026-10-02T17:01:12-04:00 https://ir.renovorx.com/sec-filings/all-sec-filings/content/0001493152-26-045578/ownership.html 2026-10-02T17:01:02-04:00 https://ir.renovorx.com/sec-filings/all-sec-filings/content/0001493152-26-045577/ownership.html 2026-10-02T17:00:59-04:00 https://ir.renovorx.com/sec-filings/all-sec-filings/content/0001493152-26-045580/ownership.html 2026-10-02T17:00:57-04:00 https://ir.renovorx.com/sec-filings/all-sec-filings/content/0001493152-26-042650/ownership.html 2026-09-15T06:07:49-04:00 https://ir.renovorx.com/sec-filings/all-sec-filings/content/0001493152-26-039472/form8-k.htm 2026-08-20T16:06:46-04:00 https://ir.renovorx.com/sec-filings/all-sec-filings/content/0001193125-26-349190/rnxt-20260630.htm 2026-08-13T16:37:55-04:00 https://ir.renovorx.com/sec-filings/all-sec-filings/content/0001193125-26-349157/rnxt-20260812.htm 2026-08-13T16:11:49-04:00 https://ir.renovorx.com/company-information/presentations/detail/22636/corporate-overview 2026-09-14T00:00:00-04:00 https://ir.renovorx.com/disclaimer https://ir.renovorx.com/sitemap https://ir.renovorx.com/accessibility-statement